Lactobacillus rhamnosus, Lactobacillus Paracasei, Lactobacillus acidophilus, Lactobacillus Sporogenes, Bifidobacterium Longum, Saccharomyces, Streptococcus Thermophilus, Clostridium butyricum, Bacillus Mesentricus Capsule

Lactobacillus rhamnosus, Lactobacillus Paracasei, Lactobacillus acidophilus, Lactobacillus Sporogenes, Bifidobacterium Longum, Saccharomyces, Streptococcus Thermophilus, Clostridium butyricum, Bacillus Mesentricus Capsule

This multi-strain probiotic and symbiotic capsule is formulated to restore and maintain healthy gut microflora. It combines beneficial bacterial and yeast strains that help balance intestinal ecology, enhance digestive efficiency, and strengthen immune defence.
It is suitable for use in gastrointestinal disorders, antibiotic-associated diarrhoea, irritable bowel syndrome (IBS), and as daily support for overall gut health.

Apixaban is a selective Factor Xa inhibitor that blocks the activity of Factor Xa—an essential enzyme in the coagulation cascade responsible for thrombin generation and clot formation.

The tablet provides rapid onset and consistent anticoagulation, with fewer dietary and drug interactions compared to traditional anticoagulants like warfarin.

Common strengths include 2.5 mg and 5 mg tablets for oral administration.

  • Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).
  • Treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Used for prophylaxis of venous thromboembolism (VTE) after hip or knee replacement surgery.
  • Suitable for long-term anticoagulation therapy under medical supervision.
  • Provides effective and stable anticoagulation without the need for INR monitoring.
  • Lower bleeding risk compared to traditional anticoagulants.
  • Rapid onset of action with predictable pharmacokinetics.
  • Convenient oral dosing, improving patient compliance.
  • Can be used safely in elderly patients with appropriate dose adjustment.